Bone Marrow Imaging and Outcomes Across Blood C cancers and Related Conditions
Official title: Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
Run by M.D. Anderson Cancer Center · NCT07743476 · Data updated 2026-11-12
This observational study follows patients undergoing bone marrow imaging to see how imaging features relate to treatments and outcomes over time.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | August 31, 2026 |
| Main results expected | December 31, 2036 |
| Study ends | December 31, 2038 |
| Registry record updated | September 18, 2026 |
| Trial ID | NCT07743476 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (and eligible pediatric participants with guardian consent) diagnosed with a hematologic or oncologic condition who are undergoing MRI-based bone marrow imaging and have relevant clinical data available.
✕Probably not a fit
Patients without bone marrow imaging data or lacking sufficient clinical data may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study collects longitudinal data from patients with hematologic and oncologic conditions who receive bone marrow imaging. Researchers will integrate imaging findings with treatment histories and clinical outcomes to describe bone marrow changes. The project aims to identify patterns between imaging, therapies, hematologic recovery, and treatment-related toxicities. It will also explore links between imaging results and laboratory or biomarker data when available. The study uses observational data collection without an interventional treatment plan.
Why it matters
Potential benefit: Findings could improve understanding of how bone marrow appears and behaves after various treatments, potentially guiding future care.
How similar studies have gone: Other observational cohorts have shown that standardized imaging integrated with clinical data can reveal meaningful patterns in bone marrow recovery and toxicity.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Diagnosis of a hematologic, oncologic, or other condition relevant to the study. * Availability of clinical, imaging, laboratory, treatment, and/or outcome data relevant to the study. * Ability to provide informed consent for prospective participation or, for pediatric participants, parent/legal guardian permission with assent when applicable. * Participants undergoing research MRI must be eligible for MRI according to institutional safety requirements. Exclusion Criteria * Inability to provide required informed consent or parental/legal guardian permission for prospective participation. * Insufficient clinical information to support study participation * Pregnancy. * Contraindication to MRI will exclude participants from research-specific MRI but not necessarily from other study components.
Where it's running
-
UT MD Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Omran Saifi, MD — UT MD Anderson Cancer Center
- Study coordinator: Omran Saifi, MD
- Email: OSaifi@mdanderson.org
- Phone: 832-829-0337
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preventing heart problems in overweight/obese young sarcoma survivors with tirzepatide
This feasibility study tests whether tirzepatide can be safely given to overweight or obese young adults (18–39) who have completed doxorubicin for soft tissue or bone sarcoma to see if it’s feasible to use in the first year after therapy.
-
Predicting lymphedema risk in inflammatory breast cancer patients using preoperative body impedance analysis
This study tests whether a preoperative bioimpedance test can help identify IBC patients who are at risk for developing lymphedema.
-
Precision genomic testing to guide first-line LBCL treatment readiness
Doctors will see if a tumor genomic test can help tailor first-line treatment for adults with LBCL by the start of the second cycle of standard therapy.
-
Using Apple Vision Pro in image-guided procedures
This study tests whether the Apple Vision Pro can be used during CT-guided biopsy procedures to help with imaging and guidance.
-
Geniculate Artery Embolization for Knee Osteoarthritis in Cancer Patients
This study tests whether blocking knee blood vessels with a standard care procedure can help reduce pain and improve function in people with knee osteoarthritis who also have cancer.
-
Urothelial Carcinoma Biospecimen Collection and Data Study
This project tests collecting and storing tissue, blood, and imaging data from adults with urothelial carcinoma to support translational research.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.